晚期糖基化终末产物用于老年心脏手术患者术前衰弱筛查
本研究为两中心前瞻性队列数据的回顾性分析,纳入555例≥70岁心脏手术患者,术前用皮肤自发荧光(SAF)评估晚期糖基化终末产物(AGEs)。SAF水平与衰弱相关,含SAF的决策算法识别衰弱的C统计量为0.72,SAF亦与1年残疾或死亡相关。
要点
- 555例≥70岁心脏手术患者中122例(22%)为衰弱。
- SAF水平与依赖居住状态(aRR 2.45)和认知受损(aRR 1.61)关联最强。
- 含SAF、性别、处方药、术前血红蛋白和EuroSCORE II的算法C统计量为0.72。
核心结论
- 较高的SAF水平与老年心脏手术患者衰弱及死亡或残疾风险增加相关。
研究设计与样本
- 两中心观察性队列研究数据的回顾性分析,纳入555例≥70岁心脏手术患者。
主要发现
- 555例患者中122例(22%)为衰弱。
- SAF水平与依赖居住状态(aRR 2.45(95% CI 1.28-4.66))和认知受损(aRR 1.61(95% CI 1.10-2.34))关联最强。
- 含SAF、性别、处方药、术前血红蛋白和EuroSCORE II的决策算法识别衰弱C统计量为0.72(95% CI 0.67-0.77)。
- SAF水平与1年残疾或死亡相关(aRR 1.38(95% CI 1.06-1.80))。
- SAF水平与严重并发症的aRR为1.28(95% CI 0.87-1.88)。
关键数值与推荐
- 衰弱定义为基于11项测试(涵盖躯体、心理和社会领域)的术前综合评估中,每个领域至少1项测试阳性。
- 主要结局为术前衰弱,次要结局为严重术后并发症及1年残疾(WHODAS 2.0问卷)或死亡的复合终点。
临床怎么用
- SAF可无创评估AGEs,该生物标志物可能优化心脏手术术前风险分层。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advanced glycation end products (AGEs) are potential biomarkers of biological age. Skin Auto Fluorescence (SAF) can assess AGEs non-invasively. We evaluated the association of SAF levels with frailty and its predictive ability for adverse outcomes in older cardiac surgery patients. METHODS: This was a retrospective analysis of prospectively acquired data from a two-center observational cohort study. We measured SAF level in cardiac surgery patients aged ≥70. Primary outcome was preoperative frailty. A comprehensive frailty assessment was performed before surgery based on 11 individual tests assessing the physical, mental, and social domain. Frailty was defined as at least 1 positive test in each domain. Secondary outcome measures were severe postoperative complications and a composite endpoint of 1-year disability (defined by WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) questionnaire) or mortality. RESULTS: Among 555 enrolled patients, 122 (22%) were frail. SAF level was most strongly associated with dependent living status (aRR 2.45 (95% CI 1.28-4.66)) and impaired cognition (aRR 1.61 (95% CI 1.10-2.34)). A decision algorithm to identify frail patients including SAF level, sex, prescription drugs, preoperative hemoglobin, and EuroSCORE II resulted in a C-statistic of 0.72 (95% CI 0.67-0.77). SAF level was also associated with disability or death after 1 year (aRR 1.38 (95% CI 1.06-1.80)). The aRR for severe complications was 1.28 (95% CI 0.87-1.88). CONCLUSIONS: Higher SAF level is associated with frailty in older cardiac surgery patients, as well as an increased risk of death or disability. This biomarker could potentially optimize preoperative risk stratification for cardiac surgery.
引用
- Smoor RM, van Dongen EPA, Verwijmeren L, et al. Advanced glycation end products for preoperative frailty screening in older cardiac surgery patients. J Am Geriatr Soc. 2023. PMID: 37021973. doi:10.1111/jgs.18361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。